skip to content

CIPIL Annual Spring Conference 2020: Is IP Good for Our Health?

Saturday 7 March 2020

Chair: Lord Justice Richard Arnold
This conference will bring together practitioners, scholars and policymakers to examine the latest decisions, research and political developments in intellectual property and health. 
Topics include: 
- The implications of non-obviousness for follow-on medical innovation (e.g., drug repurposing) after the UK Supreme Court’s 2019 decision Actavis v ICOS
- The current and future roles of competition law in controlling drug prices, including an update on Flynn and Pfizer; 
- The potential effect of Brexit on the trade of medical products; 
- The role of patents in the development of precision medicine; 
- Whether regulatory exclusivities incentivise the development of drugs, and the possible reduction of protection for biologics in the US; 
- Global access to medicines and alternatives to IP.
- Katherine Moggridge, Barrister (Three New Square); 
- Trevor Cook, Partner (WilmerHale); 
- Dr Chris Stothers, Partner (Freshfields Bruckhaus Deringer); 
- Katharine Stephens, Partner (Bird & Bird); 
- Professor Mateo Aboy (Cambridge University); 
- Dr John Liddicoat (Cambridge University); 
- Professor Wolf Sauter (Netherlands Authority for Consumers & Markets; Tilburg University); 
- Dr Ellen ‘t Hoen, Director (Medicines Law & Policy); 
- Professor Rochelle Dreyfuss (New York University); 
- Dr Kathy Liddell (Cambridge University).
To book a place on the conference, please visit our esales page. 
Enquiries to: